Samantha Semenkow
Stock Analyst at Citigroup
(0.67)
# 3,951
Out of 4,951 analysts
44
Total ratings
30.56%
Success rate
-22.32%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Samantha Semenkow
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WVE Wave Life Sciences | Initiates: Buy | $16 | $9.70 | +64.95% | 1 | Jul 16, 2025 | |
| PRME Prime Medicine | Downgrades: Neutral | $10 → $1.5 | $3.56 | -57.87% | 3 | May 27, 2025 | |
| CABA Cabaletta Bio | Maintains: Buy | $17 → $13 | $1.77 | +634.46% | 3 | May 16, 2025 | |
| ALLO Allogene Therapeutics | Maintains: Buy | $8 → $4 | $1.09 | +266.97% | 3 | May 15, 2025 | |
| ARGX argenx SE | Maintains: Buy | $796 → $803 | $663.01 | +21.12% | 6 | May 9, 2025 | |
| GPCR Structure Therapeutics | Initiates: Buy | $60 | $20.12 | +198.28% | 1 | May 2, 2025 | |
| BIOA BioAge Labs | Maintains: Neutral | $7 → $5 | $4.57 | +9.41% | 3 | Mar 24, 2025 | |
| VYGR Voyager Therapeutics | Initiates: Buy | $12 | $3.83 | +213.32% | 1 | Dec 2, 2024 | |
| CPRX Catalyst Pharmaceuticals | Maintains: Buy | $27 → $31 | $20.27 | +52.94% | 2 | Aug 9, 2024 | |
| SANA Sana Biotechnology | Maintains: Buy | $8 → $15 | $3.40 | +341.18% | 2 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $80 | $8.73 | +816.38% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $14 | $4.03 | +247.83% | 6 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $15 | $2.79 | +437.63% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $72 | $54.62 | +31.82% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $50 | $15.39 | +224.89% | 3 | Sep 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $56 | $17.70 | +216.38% | 3 | Aug 9, 2023 |
Wave Life Sciences
Jul 16, 2025
Initiates: Buy
Price Target: $16
Current: $9.70
Upside: +64.95%
Prime Medicine
May 27, 2025
Downgrades: Neutral
Price Target: $10 → $1.5
Current: $3.56
Upside: -57.87%
Cabaletta Bio
May 16, 2025
Maintains: Buy
Price Target: $17 → $13
Current: $1.77
Upside: +634.46%
Allogene Therapeutics
May 15, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.09
Upside: +266.97%
argenx SE
May 9, 2025
Maintains: Buy
Price Target: $796 → $803
Current: $663.01
Upside: +21.12%
Structure Therapeutics
May 2, 2025
Initiates: Buy
Price Target: $60
Current: $20.12
Upside: +198.28%
BioAge Labs
Mar 24, 2025
Maintains: Neutral
Price Target: $7 → $5
Current: $4.57
Upside: +9.41%
Voyager Therapeutics
Dec 2, 2024
Initiates: Buy
Price Target: $12
Current: $3.83
Upside: +213.32%
Catalyst Pharmaceuticals
Aug 9, 2024
Maintains: Buy
Price Target: $27 → $31
Current: $20.27
Upside: +52.94%
Sana Biotechnology
Aug 9, 2024
Maintains: Buy
Price Target: $8 → $15
Current: $3.40
Upside: +341.18%
Jun 3, 2024
Reinstates: Buy
Price Target: $80
Current: $8.73
Upside: +816.38%
May 22, 2024
Maintains: Buy
Price Target: $10 → $14
Current: $4.03
Upside: +247.83%
May 9, 2024
Maintains: Buy
Price Target: $16 → $15
Current: $2.79
Upside: +437.63%
Dec 8, 2023
Initiates: Buy
Price Target: $72
Current: $54.62
Upside: +31.82%
Sep 27, 2023
Maintains: Buy
Price Target: $33 → $50
Current: $15.39
Upside: +224.89%
Aug 9, 2023
Maintains: Buy
Price Target: $60 → $56
Current: $17.70
Upside: +216.38%